Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of breast cancer
3.2.1.2 Technological advancements in liquid biopsy technique
3.2.1.3 Rising awareness for early diagnosis and treatment
3.2.1.4 Expansion of research and development
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of biopsy devices
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Epidemiology scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Biomarkers, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Circulating tumor cells (CTCs)
5.3 Cell-free DNA (cfDNA)
5.4 Exosomes
5.5 Other biomarkers
Chapter 6 Market Estimates and Forecast, By Product & Services, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Kits & reagents
6.3 Services
Chapter 7 Market Estimates and Forecast, By Sample Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Blood
7.3 Urine
7.4 Other sample types
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Cancer research centers
8.4 Diagnostic centers
8.5 Academic and research institutes
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Datar Cancer Genetics
10.2 Epic Sciences
10.3 F. Hoffmann-La Roche
10.4 Genes2me
10.5 Illumina
10.6 Menarini Silicon Biosystems
10.7 Myriad Genetics
10.8 OncoDNA
10.9 QIAGEN
10.10 Sysmex Corporation
10.11 System Biosciences
10.12 Thermo Fisher Scientific
10.13 Twist Bioscience
